| Document and Entity Information - USD ($) | 3 Months Ended | |
| Mar. 31, 2015 | Jun. 30, 2014 | |
| Document and Entity Information: | ||
| Entity Registrant Name | Pazoo, Inc. | |
| Document Type | 10-Q | |
| Document Period End Date | Mar. 31, 2015 | |
| Trading Symbol | pzoo | |
| Amendment Flag | false | |
| Entity Central Index Key | 1,533,427 | |
| Current Fiscal Year End Date | --12-31 | |
| Entity Common Stock, Shares Outstanding | 107,765,750 | |
| Entity Public Float | $ 1,077,657 | |
| Entity Filer Category | Smaller Reporting Company | |
| Entity Current Reporting Status | Yes | |
| Entity Voluntary Filers | No | |
| Entity Well-known Seasoned Issuer | No | |
| Document Fiscal Year Focus | 2,015 | |
| Document Fiscal Period Focus | Q1 |
| CONSOLIDATED BALANCE SHEETS (Unaudited for March 31, 2015) - USD ($) | Mar. 31, 2015 | Dec. 31, 2014 | ||
| Current assets: | ||||
| Cash and cash equivalents | $ 17,209 | $ 733,637 | ||
| Accounts receivable | 88,770 | 87,949 | ||
| Stock subscription receivable | 12,999 | 18,253 | ||
| Inventories | 2,668 | 2,668 | ||
| Prepaid expenses | 1,465 | 6,181 | ||
| Total current assets | 123,111 | 848,688 | ||
| Intangible assets | 200,000 | |||
| Total assets | 323,111 | 848,688 | ||
| Current liabilities: | ||||
| Accounts payable and accrued liabilities | 89,347 | 84,189 | ||
| Loans payable | 3,000 | 3,000 | ||
| Interest payable | 62,602 | 46,862 | ||
| Convertible debt | 621,133 | [1] | 895,664 | [2] |
| Derivative liabilities | 1,191,670 | 2,576,025 | ||
| Total current liabilities | 1,967,752 | 3,605,740 | ||
| Long-term liabilities: | ||||
| Long-term portion of convertible debt | 62,625 | [3] | 28,832 | [4] |
| Total long-term liabilities | 62,625 | 28,832 | ||
| Total liabilities | 2,030,377 | 3,634,572 | ||
| Stockholders' deficit | ||||
| Common stock | 501,850 | 193,031 | ||
| Convertible preferred stock, Series A | 1,479 | 1,204 | ||
| Preferred stock, Series B | 1,637 | 1,187 | ||
| Convertible Preferred stock, Series C | 580 | |||
| Additional paid-in capital | 7,131,665 | 4,438,643 | ||
| Accumulated deficit | (9,344,477) | (7,419,949) | ||
| Total stockholders' deficit | (1,707,266) | (2,785,884) | ||
| Total liabilities and stockholders' equity deficit | $ 323,111 | $ 848,688 | ||
| [1] | Net of unamortized discounts of $242,308. | |||
| [2] | Net of unamortized discounts of $413,898. | |||
| [3] | Net of unamortized discounts of $690,124. | |||
| [4] | Net of unamortized discounts of $783,668. | |||
| Statement of Financial Position - Parenthetical - $ / shares | Mar. 31, 2015 | Dec. 31, 2014 |
| Common Stock, Par Value | $ 0.001 | $ 0.001 |
| Common Stock, Shares Authorized | 980,000,000 | 980,000,000 |
| Common Stock, Shares Issued | 501,850,585 | 193,030,398 |
| Common Stock, Shares Outstanding | 501,850,585 | 193,030,398 |
| Warrants Issued | 7,000,000 | 2,400,000 |
| Warrants Outstanding | 7,000,000 | 2,400,000 |
| Preferred Stock Series A | ||
| Preferred Stock, Par Value | $ 0.001 | $ 0.001 |
| Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 |
| Preferred Stock, Shares Issued | 1,478,526 | 1,203,526 |
| Preferred Stock, Shares Outstanding | 1,478,526 | 1,203,526 |
| Preferred Stock Series B | ||
| Preferred Stock, Par Value | $ 0.001 | $ 0.001 |
| Preferred Stock, Shares Authorized | 2,500,000 | 2,500,000 |
| Preferred Stock, Shares Issued | 1,637,500 | 1,187,500 |
| Preferred Stock, Shares Outstanding | 1,637,500 | 1,187,500 |
| Preferred Stock Series C | ||
| Preferred Stock, Par Value | $ 0.001 | $ 0.001 |
| Preferred Stock, Shares Authorized | 7,500,000 | 7,500,000 |
| Preferred Stock, Shares Issued | 580,000 | 0 |
| Preferred Stock, Shares Outstanding | 580,000 | 0 |
| CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) | 3 Months Ended | |
| Mar. 31, 2015 | Mar. 31, 2014 | |
| Revenues | ||
| Merchandise sales - revenue | $ 218 | |
| Advertising sales | $ 20,233 | 17,109 |
| Total revenues | 20,233 | 17,327 |
| Cost of goods sold | ||
| Merchandise sales - costs | 325 | |
| Total cost of goods sold | 325 | |
| Gross profit | 20,233 | 17,002 |
| Selling, general and administrative expenses | 1,080,862 | 206,458 |
| Professional fees | 228,521 | 35,433 |
| Website setup | 57,120 | 22,408 |
| Total operating expenses | 1,366,503 | 264,299 |
| Loss from operations | (1,346,270) | (247,297) |
| Other expenses: | ||
| Gain/(loss) on derivative liability | 439,113 | (376,187) |
| Impairment loss on investments | (499,000) | |
| Interest expense | 518,371 | (23,804) |
| Net loss | (1,924,528) | (647,288) |
| Series A preferred stock dividend | (8,962) | (5,672) |
| Net loss attributable to common stockholders | $ (1,933,490) | $ (652,960) |
| Weighted average common shares outstanding - Basic and diluted | 294,471,692 | 105,994,083 |
| Net loss per common share - Basic and diluted | $ (0.01) | $ (0.01) |
| CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) | 3 Months Ended | |
| Mar. 31, 2015 | Mar. 31, 2014 | |
| Cash flows from operating activities: | ||
| Net loss | $ (1,924,528) | $ (647,288) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock-based compensation | 862,800 | 110,991 |
| (Gain)/loss on derivative liabilities | (439,113) | 376,187 |
| Impairment loss on equity method investment | 499,000 | |
| Amortization of debt discounts | 451,693 | 17,804 |
| Loss on true-up of convertible notes | 34,383 | |
| Additional common shares issued for true-up of convertible notes | 51,470 | |
| Changes in operating assets and liabilities: | ||
| Accounts receivable (increase/decrease) | (821) | (7,537) |
| Stock subscription receivable (increase/decrease) | 5,254 | |
| Inventories (increase/decrease) | 1,565 | |
| Prepaid expenses and other current assets (increase/decrease) | 4,716 | (22,147) |
| Accounts payable and accrued liabilities (increase/decrease) | 5,159 | 12,076 |
| Interest payable (increase/decrease) | 66,679 | 6,000 |
| Net cash used in operating activities | (383,308) | (152,349) |
| Cash flows from investing activities: | ||
| Deposit made on acquisition of investment | (50,000) | |
| Cash paid for intangible asset | (200,000) | |
| Equity investment in equity method investee | (499,000) | |
| Net cash used in investing activities | (699,000) | (50,000) |
| Cash flows from financing activities: | ||
| Borrowings on convertible note, net of original issue discounts | 82,500 | 55,000 |
| Proceeds from issuing common stock | 48,380 | |
| Proceeds from exercise of Series A preferred warrants | 40,000 | |
| Proceeds from sale of Series A preferred stock and warrants | 235,000 | 100,000 |
| Net cash provided by financing activities | 365,880 | 195,000 |
| Net increase in cash and cash equivalents | (716,428) | (7,349) |
| Cash and cash equivalents beginning of period | 733,637 | 35,848 |
| Cash and cash equivalents end of period | 17,209 | 28,499 |
| Noncash Investing and Financing Activities | ||
| Common stock issued for the conversion of Series A preferred stock | 60,000 | 1,700 |
| Debt discounts due to derivative liabilities | 181,803 | 60,500 |
| Payments of accounts payable by third party | 2,075 | |
| Original issue discount on convertible note | $ 5,500 | |
| Resolution of derivative liabilities | 1,126,245 | |
| Common shares issued for conversion of debt and interest | $ 679,251 | |
